High or low doses of ACE inhibitors for heart failure?

Cleveland Clinic Journal of Medicine

Volumn 65, Issue 10, 1998, Pages 539-542

  Hobbs, Robert E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; QUINAPRIL; RAMIPRIL; TRANDOLAPRIL;

ARTICLE; CLINICAL TRIAL; DRUG MEGADOSE; DRUG SCREENING; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPOKALEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRACTICE GUIDELINE; TREATMENT OUTCOME; UREMIA; VERTIGO; ADULT; AGED; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FORWARD HEART FAILURE; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC OUTPUT, LOW; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LENGTH OF STAY; LISINOPRIL; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032215439     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.65.10.539     Document Type: Article

References (21)

1. Davis R, Ribner HS, Keung E, Sonnenblick E, LeJemtel T. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. N Engl J Med 1979; 301:117-121.
2. Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory congestive heart failure. J Am Coll Cardiol 1983; 4:755-763.
3. Kramer BL, Massie BM, Topic N. Controlled trial of captopril in chronic congestive heart failure: a rest and exercise hemodynamic study. Circulation 1983; 67:807-816.
4. Sharpe DN, Murphy J, Coxon R, Hannan S. Enalapril in patients with chronic congestive heart failure: a placebo-controlled, randomized, double blind study. Circulation 1984; 70:271-278.
5. Levine TB, Olivari MT, Garberg U, Sharkey SW, Cohn JN. Hemodynamic and clinical response to enalapril, a long-acting converting enzyme inhibitor, in patients with congestive heart failure. Circulation 1984; 69:528-533.
6. Packer M, Medina N, Yushak M, Meller J. Hemodynamic patterns of response during long-term captopril therapy for severe chronic congestive heart failure. Circulation 1983; 68:803-812.
7. Schwartz AB, Chatterjee J. Vasodilator therapy in chronic congestive heart failure. Drugs 1983; 26:148-173.
8. Romankiewicz JA, Brogden RN, Heel RC, et al. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Drugs 1983; 25:6-40.
9. Chalmers JP, West MJ, Cyran J, et al. Placebo-controlled study of lisinopril in congestive heart failure: a multicenter study. J Cardiovasc Pharmacol 1987; 9(Suppl 3):s89-s98.
10. Giles TD, Katz R, Sullivan JR, et al. Short-and long-acting angiotensin converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. J Am Coll Cardiol 1989; 13:1240-1247.
11. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative north Scandinavian enalapril survival study. N Engl J Med 1987; 316:1429-1435.
12. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.
13. Pfeffer MA, Braunwald E, Moye LA, et al, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327:669-677.
14. Cohn JN, Johnson MS, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:303-310.
15. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998; 97:2202-2212.
16. Pitt B. Angiotensin-converting inhibitors in patients with congestive heart failure: a class effect? Am J Cardiol 1991; 68:106-107.
17. Francis GS. Congestive heart failure management: the impact of medication therapy on survival. Am Heart J 1998; 115:699-701.
18. Wilson JR, Schwartz JS, Sutton MSJ, et al. Prognosis in severe congestive heart failure: relating to hemodynamic measurement and ventricular ectopic activity. J Am Coll Cardiol 1983; 2:403-410.
19. Packer M. How should we judge the efficacy of medication treatment in patients with chronic CHF? The insights of six blind men. J Am Coll Cardiol 1987; 9:433-438.
20. Uretsky BF, Shaver JA, Chang-Seng L, et al. Modulation of hemodynamic effects with converting enzyme inhibitor: acute hemodynamic dose response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observation on long term clinical, functional and biochemical responses. Am Heart J 1988; 116:480-488.
21. Rieggar GAJ. Effects of quinapril on exercise tolerance testing in patients with mild to moderate congestive heart failure. Eur Heart J 1991; 12:705-711.